Skip to main content
SpringerLink
Log in

Hemofiltration in Sepsis and Septic Shock

  • Conference paper
Yearbook of Intensive Care and Emergency Medicine 1997

Part of the book series: Yearbook of Intensive Care and Emergency Medicine ((YEARBOOK,volume 1997))

Abstract

Sepsis and septic shock are leading causes of morbidity and mortality in the intensive care setting. The mortality rate in patients with septic shock ranges from 40 to 80%. The primary therapeutic strategy for septic shock involves, on the one hand, hemodynamic stabilization including restoration of blood pressure, and optimization of oxygen delivery [1, 2], and on the other hand, administration of antibiotics together with removal of the septic source whenever indicated. Several clinical studies have demonstrated a close relationship between the severity of sepsis, mortality rate, and the release of cytokines including tumor necrosis factor (TNF), and interleukins (IL)-1, IL-6, and IL-8 [3–6]. The release of various mediators can be involved in reduction in myocardial contractility, increase in oxygen demand, and alteration in oxygen extraction capabilities during septic shock [7]. Modulation of the immune response is therefore considered as another important therapeutic intervention. A number of clinical trials investigating the effects of anti-endotoxin, or anti-cytokine interventions did not consistently show an improvement in survival in patients with sepsis or septic shock [8, 9]. Importantly, various factors such as inclusion criteria, dose, and timing could influence the results. Moreover, a single immunotherapy may not be sufficient to blunt the inflammatory and immunological process, so that a combination of therapies may be necessary to improve outcome from septic shock.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Shoemaker WC (1987) Circulatory mechanisms of shock and their mediators. Crit Care Med 15: 787–794

    Article  PubMed  CAS  Google Scholar 

  2. Edwards JD, Brown GCS, Nightingale P, et al (1989) The use of survivors’ cardiorespiratory values as therapeutic goals in septic shock. Crit Care Med 17: 1098–1103

    Article  PubMed  CAS  Google Scholar 

  3. Parrillo JE (1993) Pathogenetic mechanisms of septic shock. N Engl J Med 328: 1471–1477

    Article  PubMed  CAS  Google Scholar 

  4. Damas P, Reuter A, Gysen P, et al (1989) Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. Crit Care Med 17: 975–979

    Article  PubMed  CAS  Google Scholar 

  5. Calandra T, Baumgartner JD, Grau DG, et al (1990) Prognostic values of tumor necrosis factor/cachectin, interleukin-1, interferon-alpha, and interferon-gamma in the serum of patients with septic shock. J Infect Dis 161: 982–987

    Article  PubMed  CAS  Google Scholar 

  6. Pinsky MR, Vincent JL, Kahn RJ, et al (1990) Inflammatory mediators of septic shock in man. Am Rev Respir Dis 141: A512 (Abst)

    Google Scholar 

  7. Vincent JL (1991) Diagnostic and medical management/supportive care of patients with Gram-negative bacteremia and septic shock. Infect Dis Clin North Am 5: 807–816

    PubMed  CAS  Google Scholar 

  8. Hoffman WD, Natanson C (1993) The role of endotoxin in bacterial septic shock. In: Vincent JL (ed) Yearbook of Intensive Care and emergency medicine 1993. Springer, Berlin Heidelberg New York, pp 49–63

    Google Scholar 

  9. Fisher C (1992) Clinical trials of immunotherapy for sepsis. Crit Care Med 20: 721–723

    Article  Google Scholar 

  10. Gomez A, Wang R. Unruh H, et al (1990) Hemofiltration reverses left ventricular dysfunction during sepsis in dogs. Anesthesiology 73: 671–685

    Article  PubMed  CAS  Google Scholar 

  11. Stein B, Pfenninger E, Grunert A, et al (1990) Influence of continuous hemofiltration on hemodynamics and central blood volume in experimental endotoxic shock. Intensive Care Med 16: 494–499

    Article  PubMed  CAS  Google Scholar 

  12. Freeman BD, Yatsiv I, Natanson C, et al (1995) Continuous arteriovenous hemofiltration does not improve survival in a canine model of septic shock. J Am Coll Surg 180: 286–292

    PubMed  CAS  Google Scholar 

  13. Lee PA, Matson JR, Pryor RW, et al (1993) Continuous arteriovenous hemofiltration therapy for Staphylococcus aureus-induced septicemia in immature swine. Crit Care Med 21: 914–924

    Article  PubMed  CAS  Google Scholar 

  14. Mink SN, Jha P, Wang R, et al (1995) Effects of continuous arteriovenous hemofiltration with systemic vasopressor therapy on depressed left ventricular contractility and tissue oxygen delivery in canine Escherichia coli sepsis. Anesthesiology 83: 178–190

    Article  PubMed  CAS  Google Scholar 

  15. Heidemann SM, Ofenstein JP, Sarnaik AP (1994) Efficacy of continuous arteriovenous hemofiltration in endotoxic shock. Circ Shock 44: 183–187

    PubMed  CAS  Google Scholar 

  16. Grootendorst AF, van Bommel EFH, van der Hoven B, et al (1992) High-volume hemofiltration improves hemodynamics of endotoxin-induced shock in the pig. J Crit Care 7: 67–75

    Article  Google Scholar 

  17. Grootendorst AF, van Bommel EFH, van der Hoven B, et al (1992) High volume hemofiltration improves right ventricular function of endotoxin-induced shock in the pig. Intensive Care Med 18: 235–240

    Article  PubMed  CAS  Google Scholar 

  18. Grootendorst AF, van Bommel EF, van Leengoed LA, et al (1994) High volume hemofiltration improves hemodynamics and survival of pigs exposed to gut ischemia and reperfusion. Shock 2: 72–78

    Article  PubMed  CAS  Google Scholar 

  19. Rogiers P, Zhang H, Smail N, et al (1996) High-volume hemofiltration improves hemodynamics in experimental endotoxic shock. Intensive Care Med 22: S396 (Abst)

    Google Scholar 

  20. Grootendorst AF, van Bommel EFH, van der Hoven B, et al (1993) Infusion of ultrafiltrate from endotoxemic pigs depresses myocardial performance in normal pigs. J Crit Care 8: 161–169

    Article  PubMed  CAS  Google Scholar 

  21. Wendon J, Smithies M, Sheppard M, et al (1989) Continuous high volume veno-venous hemofiltration in acute renal failure. Intensive Care Med 15: 358–363

    Article  PubMed  CAS  Google Scholar 

  22. Mauritz W, Sporn P, Schindler I, et al (1986) Acute renal failure in abdominal infection. Comparison of haemodialysis and continuous arteriovenous hemofiltration. Anesth Intensivther Notfallmed 21: 212–217

    Google Scholar 

  23. van Bommel E, Bouvy ND, So KI, et al (1995) Acute dialytic support for critically ill: Intermittent hemodialysis versus continuous arteriovenous hemodiafiltration. Am J Nephrol 15: 192–200

    Google Scholar 

  24. Lingnau W, Javorsky F, Resch D, et al (1995) Continuous hemofiltration improves multiple organ failure and outcome. Crit Care Med 23: A106 (Abst)

    Google Scholar 

  25. Vincent JL, Tielemans C (1995) Continuous hemofiltration in severe sepsis: Is it beneficial? J Crit Care 10: 27–32

    Article  PubMed  CAS  Google Scholar 

  26. Goldfarb S, Golper TA (1994) Pro-inflammatory cytokines and hemofiltration membranes. J Am Soc Nephrol 5: 228–232

    PubMed  CAS  Google Scholar 

  27. Sato T, Orlowski JP, Zborowski M (1993) Experimental study of extracorporeal perfusion for septic shock. ASAIO J 39: M790 - M793

    Article  PubMed  CAS  Google Scholar 

  28. Gotloib L, Barzilay E, Shustak A, et al (1986) Hemofiltration in septic ARDS. The artificial kidney as an artificial endocrine lung. Resuscitation 13: 123–132

    Google Scholar 

  29. Bellomo R (1995) Continuous hemofiltration as blood purification in sepsis. New Horizons 3: 732–737

    PubMed  CAS  Google Scholar 

  30. Cheadle WG, Hanasawa K, Gallinaro RN, et al (1991) Endotoxin filtration and immune stimulation improve survival from gram-negative sepsis. Surgery 110: 785–792

    PubMed  CAS  Google Scholar 

  31. Schiffl H, Lang SM, König A, et al (1994) Biocompatible membranes in acute renal failure: Prospective case-controlled study. Lancet 344: 570–572

    Google Scholar 

  32. Hakim RM, Wingard RL, Parker RA (1994) Effect of the dialysis membrane in the treatment of patients with acute renal failure. N Engl J Med 331: 1338–1342

    Article  PubMed  CAS  Google Scholar 

  33. Gasche Y, Pascual M, Suter PM, et al (1996) Complement depletion during haemofiltration with polyacrilonitrile membranes. Nephrol Dial Transplant 11: 117–119

    Article  PubMed  CAS  Google Scholar 

  34. Millar AB, Armstrong L, van der Linden (1993) Cytokine production and hemofiltration in children undergoing cardiopulmonary bypass. Ann Thorac Surg 56: 1499–1502

    Article  PubMed  CAS  Google Scholar 

  35. van Bommel EFH, Hesse CJ, Jutte NHPM, et al (1995) Cytokine kinetics (TNF-a, IL-1ß, IL-6) during continuous hemofiltration: A laboratory and clinical study. In: Sieberth HG, Stummvoll HK, Kierdort H (eds) Continuous extracorporeal treatment in multiple organ dysfunction syndrome. Karger, Basel, pp 62–75

    Google Scholar 

  36. Hoffmann JN, Hartl WH, Deppisch R, et al (1995) Hemofiltration in human sepsis: Evidence for elimination of immunomodulatory substances. Kidney Int 48: 1563–1570

    Google Scholar 

  37. Bellommo R, Tipping P, Boyce N (1995) Interleukin-6 and interleukin-8 extraction during continuous venovenous hemodiafiltration in septic acute renal failure. Renal Failure 17: 457–466

    Article  Google Scholar 

  38. Hirasawa H, Sugai T, Ohtake Y, et al (1991) Continuous hemofiltration and hemodiafiltration in the management of multiple organ failure. In: Sieberth HG, Mann H, Stummvoll HK (eds) Continuous hemofiltration. Karger, Basel, pp 42–46

    Google Scholar 

  39. Staubach KH, Rau HG, Hohlbach G, et al (1987) Continuous arteriovenous hemofiltration in shock: A new strategy to lower eicosanoids. Artif Organs 11: A336 (Abst)

    Google Scholar 

  40. Tonnesen E, Hansen MB, Hohndrof K, et al (1993) Cytokines in plasma and ultrafiltrate during continuous arteriovenous haemofiltration. Anaesth Intensive Care 21: 752–758

    PubMed  CAS  Google Scholar 

  41. Coraim F, Pauser G, Stellwag F, et al (1985) Positive modification of hemodynamics in postcardiac surgery patients by hemofiltration. Improved method for the demonstration of myocardial depressant factor in hemofiltrate. Anaesthesist 34: 236–240

    Google Scholar 

  42. Garzia F, Todor R, Scalea T (1991) Continuous arteriovenous hemofiltration: Counter current dialysis in acute respiratory failure. J Trauma 31: 1277–1285

    Google Scholar 

  43. Bellomo R, Tipping P, Boyce N (1993) Continuous veno-venous hemofiltration with dialysis removes cytokines from the circulation of septic patients. Crit Care Med 21: 522–526

    Article  PubMed  CAS  Google Scholar 

  44. Gotloib L, Shostak A, Lev A, et al (1995) Treatment of surgical and non-surgical septic multi-organ failure with bicarbonate hemodialysis and sequential hemofiltration. Intensive Care Med 21: 104–111

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. P. Rogiers
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J.-L. Vincent
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Intensive Care, Erasme Hospital, Free University of Brussels, Route de Lennik 808, B-1070, Brussels, Belgium

    Jean-Louis Vincent (Clinical Director) (Clinical Director)

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Rogiers, P., Zhang, H., Vincent, JL. (1997). Hemofiltration in Sepsis and Septic Shock. In: Vincent, JL. (eds) Yearbook of Intensive Care and Emergency Medicine 1997. Yearbook of Intensive Care and Emergency Medicine, vol 1997. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-13450-4_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-13450-4_13

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-13452-8

  • Online ISBN: 978-3-662-13450-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation